pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,763 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 14 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,159
  • 8k filing2,286
  • pdufa315
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›ACTIVE_NOT_RECRUITINGphase readoutNCT05433025: A Novel Device for Neck Pain in Active-duty Military Personnel With Forward Head Posture.

Sponsor: Kessler Foundation. Phase: NA. Conditions: Neck Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07519876: Pulmonary Embolism and Right-to-Left Shunts

Sponsor: Tufts Medical Center. Phase: . Conditions: Pulmonary Embolism (PE), Right-to-Left Shunt, Stroke, Atrial Septal Defects, Patent Foramen Ovale (PFO), Pulmonary Arteriovenous Malformation

full page →ctgov ↗
›RECRUITINGphase readoutNCT07193407: INOPASE - Performance and Safety Study of a Personalised SNM System

Sponsor: INOPASE Pty Ltd. Phase: NA. Conditions: Overactive Bladder (OAB)

full page →ctgov ↗
›SUSPENDEDphase readoutNCT07429591: Risk Screening & Primary Prevention of Elder Abuse in People Living With Dementia

Sponsor: University of Southern California. Phase: NA. Conditions: Caregivers of Alzheimer's Disease or Memory Problem Patients, Caregiver Wellbeing, Elder Abuse

full page →ctgov ↗
›RECRUITINGphase readoutNCT05432297: Preventive Physical Activity Intervention in Head and Neck Cancer

Sponsor: Sahlgrenska University Hospital. Phase: NA. Conditions: Head and Neck Neoplasms, Physical Inactivity

full page →ctgov ↗
›COMPLETEDphase readoutNCT07442110: This Observational Study Evaluates the Clinical Outcomes of Patients With Diabetes Who Utilize a Specialized Dietary Supplements for Foot Ulcer Healing. The Study Documents the Rate of Complete Wound Closure and the Prevention of Lower Extremity Amputations in a Real-world, At-home Setting.

Sponsor: Amar h Zireg. Phase: . Conditions: Limb Salvage, Diabetes Complication, Dietary Supplements, Healed Ulcer, Wound Closure, At Home Setting, Diabetes Mellitus, Type 1, Type 2, Wound Healing, Diabetic Foot Ulcer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07254910: Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma

Sponsor: University of Oklahoma. Phase: NA. Conditions: CRC Screening, CRC (Colorectal Cancer)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07245810: Stryker Facial iD Universal Plate Configurator: A Retrospective Post Market Follow Up

Sponsor: Stryker Craniomaxillofacial. Phase: . Conditions: Mandibular Fractures, Facial Fracture, Maxilla Fracture, Orthognathic Surgical Procedures

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07462910: Diaphragmatic Evaluation by Fluoroscopy to Identify Phrenic Nerve Dysfunction Related to Electroporation

Sponsor: French Cardiology Society. Phase: NA. Conditions: Atrial Fibrillation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07523360: A Digital Cognitive Intervention for Intrusive Memories After Trauma

Sponsor: Zhu Zijian. Phase: NA. Conditions: Post-Traumatic Stress Disorder (PTSD), Intrusive Memories of Traumatic Event(s)

full page →ctgov ↗
›COMPLETEDphase readoutNCT06820320: Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: PHASE2. Conditions: Chylous Ascites, Abdominal Neoplasm, Pelvic Neoplasms, Retroperitoneal Lymph Node Metastasis, Retroperitoneal Lymphadenectomy, Extended Lymphadenectomy

full page →ctgov ↗
›RECRUITINGphase readoutNCT04746820: Functional Near-infrared Spectroscopy in Unconscious Patients

Sponsor: Emanuela Keller. Phase: NA. Conditions: Nervous System Diseases, Healthy Subjects

full page →ctgov ↗
›RECRUITINGphase readoutNCT06563323: Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG)

Sponsor: Oregon Health and Science University. Phase: PHASE2. Conditions: Pyoderma Gangrenosum, Skin Diseases, Wound Heal, Pyoderma, Skin Ulcer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07525596: Social Work-Supported Physiotherapy and Psychosocial Outcomes in Third Age University and Nursing Home Residents

Sponsor: Munzur University. Phase: NA. Conditions: Social Work, Psychiatric, Physiotherapy

full page →ctgov ↗
›COMPLETEDphase readoutNCT05003362: ACT for High Frequency Migraine; A Virtual Mindfulness Intervention

Sponsor: Brigham and Women's Hospital. Phase: NA. Conditions: Migraine

full page →ctgov ↗
›RECRUITINGphase readoutNCT07537062: The EFFECT of VİRTUAL REALİTY HEADSETS on ANXİETY, FEAR and PHYSİOLOGICAL PARAMETERS in CHİLDREN With CANCER UNDERGOİNG INTRATHECAL CHEMOTHERAPY

Sponsor: TC Erciyes University. Phase: NA. Conditions: Pediatric Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06705803: Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE)

Sponsor: University of Chicago. Phase: . Conditions: Prostate Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01742403: Continuous Monitoring of Prostate Position During Radiotherapy

Sponsor: Royal North Shore Hospital. Phase: NA. Conditions: Prostate Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07461727: An Open-Label, Single-Arm, Dose-Escalation Phase I Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of EDB-102 in Patients With EGFR L858R-Mutant, Third-Generation TKI-Resistant Advanced Non-Small Cell Lung Cancer With Liver Metastases

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: PHASE1. Conditions: Non-Small Cell Lung Cancer, Metastatic Non-small Cell Lung Cancer, Liver Metastases, EGFR Gene Mutation, EGFR L858R

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05026827: Iyengar Yoga for Prolonged Grief Disorder

Sponsor: Medical College of Wisconsin. Phase: NA. Conditions: Prolonged Grief Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT03295227: Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Stage III Thymoma AJCC v8, Stage IIIA Thymoma AJCC v8, Stage IIIB Thymoma AJCC v8, Stage IV Thymoma AJCC v8, Stage IVA Thymoma AJCC v8, Stage IVB Thymoma AJCC v8, Unresectable Thymic Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06905561: Topical Diclofenac for Prevention of Radiation-induced Dermatitis

Sponsor: The Second Affiliated Hospital of Hainan Medical University. Phase: NA. Conditions: Head and Neck Tumor, Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07526961: Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland

Sponsor: Bristol-Myers Squibb. Phase: . Conditions: Non-Small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07325461: Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes

Sponsor: Tandem Diabetes Care, Inc.. Phase: NA. Conditions: Diabetes Mellitus, Type 1

full page →ctgov ↗
›RECRUITINGphase readoutNCT04864886: Metabolic Profiling of Immune Responses in Immune-mediated Diseases

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Primary Immunodeficiency, Psoriasis, Atopic Dermatitis, Immune-mediated Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT07447570: Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: PHASE2. Conditions: Head and Neck Cancer, Radiotherapy, Anti-PD-1/CTLA-4 Antibody

full page →ctgov ↗
›RECRUITINGphase readoutNCT07326670: Effects of Spinal vs General Anesthesia on Systemic Inflammation in PCNL

Sponsor: Elazıg Fethi Sekin Sehir Hastanesi. Phase: . Conditions: Anesthesia Techniques, Percutaneous Nephrolithotomy, Systemic Inflammation

full page →ctgov ↗
›RECRUITINGphase readoutNCT06991270: OMNI 3.1 Surgical System in Subjects With Primary Open-Angle Glaucoma

Sponsor: Sight Sciences, Inc.. Phase: NA. Conditions: Primary Open Angle Glaucoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06397573: Ablative Stereotactic MR-Guided Adaptive Reirradiation

Sponsor: Baptist Health South Florida. Phase: NA. Conditions: Abdominal Cancer, Pelvic Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05010473: Cortical Contributions to Frequency Following Responses and Modulation

Sponsor: Northwestern University. Phase: NA. Conditions: Language

full page →ctgov ↗
›RECRUITINGphase readoutNCT06609473: Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors

Sponsor: Dana-Farber Cancer Institute. Phase: NA. Conditions: Childhood Cancer, Childhood Cancer Survivors

full page →ctgov ↗
›COMPLETEDphase readoutNCT05411341: Comparison of Two Different Optical Biometric Systems

Sponsor: Democritus University of Thrace. Phase: . Conditions: Cataract, Presbyopia, Ocular Biometry, Intraocular Lens

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01580241: Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer

Sponsor: University of Oklahoma. Phase: . Conditions: Pancreatic Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07225283: Developing Resiliency and Exercise Using AI-based Messaging

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Diabetes Mellitus Type 2

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07506954: Impact of Sound Shower Music Diffusion on Family Anxiety in Intensive Care Unit Waiting Room

Sponsor: University Hospital, Tours. Phase: NA. Conditions: Anxiety

full page →ctgov ↗
›RECRUITINGphase readoutNCT06588166: Microbiome Testing for the Screening of Colorectal Cancer

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Colorectal Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07477366: Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma

Sponsor: ImmunityBio, Inc.. Phase: PHASE2. Conditions: Relapsed B-Cell Non-Hodgkin Lymphoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT03438994: Early Assessment of Autism Through Smart Tablet Gameplay

Sponsor: University of Strathclyde. Phase: NA. Conditions: Autism Spectrum Disorder, Other Neurodevelopmental Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07518966: Association Between Early Recurrence and Long-Term Recurrence After Pulsed Field Ablation for Atrial Fibrillation: Prospective Real-World Evidence From China

Sponsor: West China Hospital. Phase: . Conditions: Atrial Fibrillation (AF)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07226817: A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants

Sponsor: Bristol-Myers Squibb. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗
›COMPLETEDphase readoutNCT07426640: Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation

Sponsor: Al Mouwasat Hospital. Phase: NA. Conditions: Premature (Early) Ejaculation

full page →ctgov ↗
›COMPLETEDphase readoutNCT01675440: Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement

Sponsor: Medtronic Cardiovascular. Phase: . Conditions: Severe Aortic Stenosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06854640: A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy

Sponsor: Bayer. Phase: PHASE1. Conditions: Sepsis, Coagulopathy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05261750: Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer

Sponsor: PT. Prodia Stem Cell Indonesia. Phase: PHASE1. Conditions: Nasopharyngeal Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03971591: Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors

Sponsor: Medical College of Wisconsin. Phase: NA. Conditions: Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05766891: Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06455774: The Wearable Postural Feedback Devices Combined With Exercise in Office Workers With Chronic Neck Pain

Sponsor: Istanbul University - Cerrahpasa. Phase: NA. Conditions: Neck Pain

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07161518: Characterizing Transcranial Focused Ultrasound Neuromodulation During Sedation

Sponsor: Stanford University. Phase: PHASE4. Conditions: Healthy Participants

full page →ctgov ↗
›RECRUITINGphase readoutNCT07264790: Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon

Sponsor: Duke University. Phase: PHASE1. Conditions: Breast Reconstruction, Perfusion; Complications, High Risk for Breast Cancer, Genetic Predisposition

full page →ctgov ↗
›RECRUITINGphase readoutNCT05848713: AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

Sponsor: University of Manitoba. Phase: PHASE3. Conditions: Community-acquired Pneumonia

full page →ctgov ↗
← prev
page 59 of 156
next →